TGFBR1*6A and Int7G24A variants of transforming growth factor-β receptor 1 in Swedish familial and sporadic breast cancer

British Journal of Cancer

Volumn 97, Issue 8, 2007, Pages 1175-1179

  Song, B ^a,b   Margolin, S ^c   Skoglund, J ^a   Zhou, X ^a   Rantala, J ^a   Picelli, S ^a   Werelius, B ^a   Lindblom, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Breast cancer; Familial; Polymorphism; Sporadic; Transforming growth factor receptor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; ISOPROTEIN; PROTEIN SERINE THREONINE KINASE; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CENTER; CANCER RISK; CLINICAL FEATURE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; INT7G24A GENE; MAJOR CLINICAL STUDY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; BREAST TUMOR; CANCER STAGING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PEDIGREE; POLYMERASE CHAIN REACTION; RISK FACTOR; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RISK FACTORS; SWEDEN;

EID: 35348908317     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603961     Document Type: Article

References (23)

1. Arver B, Borg A, Lindblom A (2001) First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 5: 1-8
2. Baxter SW, Choong DY, Eccles DM, Campbell IG (2002) Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 11: 211-214
3. Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, Watson P, Lynch HT, de la Chapelle A, Fodde R, Pasche B (2005) TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 23: 3074-3078
4. Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, Reiss M (1999) Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 82: 43-51
5. Chen T, Jackson C, Costello B, Singer N, Colligan B, Douglass L, Pemberton J, Deddens J, Graff JR, Carter JH (2004) An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 112: 420-425
6. Chen T, Jackson CR, Link A, Markey MP, Colligan BM, Douglass LE, Pemberton JO, Deddens JA, Graff JR, Carter JH (2006) Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer. Clin Cancer Res 12: 392-397
7. Hemminki K, Forsti A (2002) Proper controls for SNP studies? Carcinogenesis 23: 1405
8. Houlston RS, Peto J (2004) The search for low-penetrance cancer susceptibility alleles. Oncogene 23: 6471-6476
9. Jin Q, Hemminki K, Grzybowska E, Klaes R, Soderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B, Pamula J, Pekala W, Forsti A (2004) Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers. Int J Cancer 112: 94-99
10. Kaklamani V, Pasche B (2005) Transforming growth factor beta and breast cancer. Cancer Treat Res 126: 129-156
11. Kaklamani VG, Pasche B (2004) Role of TGF-beta in cancer and the potential for therapy and prevention. Expert Rev Anticancer Ther 4: 649-661
12. Kaklamani VG, Hou N, Bian Y, Reich J, Offit K, Michel LS, Rubinstein WS, Rademaker A, Pasche B (2003) TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol 21: 3236-3243
13. Lindblom A (1993) A Molecular Study on Familial Breast Cancer. Stockholm: Departments of Clinical Genetics and Oncology, Karolinska Hospital, Karolinska Institute
14. Margolin S, Johansson H, Rutqvist LE, Lindblom A, Fornander T (2006) Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm county. Fam Cancer 5: 309-321
15. Margolin S, Werelius B, Fornander T, Lindblom A (2004) BRCA1 mutations in a population-based study of breast cancer in Stockholm county. Genet Test 8: 127-132
16. Newman B, Austin MA, Lee M, King MC (1988) Inheritance of human breast cancer: evidence for autosomal dominant transmission in highrisk families. Proc Natl Acad Sci USA 85: 3044-3048
17. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49: 33-64, 1
18. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T (2004) TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 22: 756-758
19. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, Brener D, Yang D, Kirstein L, Oddoux C, Ostrer H, Vineis P, Varesco L, Jhanwar S, Luzzatto L, Massague J, Offit K (1999) TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res 59: 5678-5682
20. Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31: 33-36
21. The National Board of Health and Welfare (2007) Cancer incidence in Sweden 2005. http://www.socialstyrelsen.se/statistik/statistik_amne/cancer
22. Thompson D, Easton D (2004) The genetic epidemiology of breast cancer genes. J Mammary Gland Biol Neoplasia 9: 221-236
23. Zhang HT, Fei QY, Chen F, Qi QY, Zou W, Wang JC, Zhang RM, Tao SH, Chen XF, Luo ZW (2003) Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. Lung Cancer 40: 281-287